Three drugs were assayed for their capacity to inhibit hepatitis B surface antigen (HBsAg) production by the PLC/PRF/5 human hepatoma cell line. The effect on cell growth and HBsAg production of Cordycepin, 6-azauridine, and Hygromicin B is reported. Hygromicin B, a translation inhibitor unable to p
Hepatitis B surface antigen produced by a human hepatoma cell line
β Scribed by Skelly, Jacinta; Copeland, Jennifer A.; Howard, C. R.; Zuckerman, A. J.
- Book ID
- 109716923
- Publisher
- Nature Publishing Group
- Year
- 1979
- Tongue
- English
- Weight
- 212 KB
- Volume
- 282
- Category
- Article
- ISSN
- 0028-0836
- DOI
- 10.1038/282617a0
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis B virus surface antigen (HBsAg) could be studied until recently only by isolating it from the blood of carriers, thus making incorporation of radioactive precursors into this protein(s) impossible. The isolation of a cell line producing HBsAg [Alexander et al, 1978] has eliminated this obs
The human hepatoblastoma-derived cell line HB6 I I secretes hepatitis-B surface antigen (HBsAg) and hepatitis-B e antigen (HBeAg) into the medium. Hepatitis-B-virus(HBV) DNA integrated into the cellular genome was found to be hypermethylated. When the cells were treated with 5-azacytidine for 3 days
## Abstract The recombinant human monoclonal antibody (MAb) against hepatitis B virus (HBV) surface antigen (HBsAg) was expressed in tobacco suspension cultures. The parental CL4MAb was produced by the EpsteinβBarr virus (EBV) transformed human cell line TAPC301βCL4. The CL4MAb cDNA was introduced